Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment, Emotion, and Neuromodulation of Depression (TREND) Study

NCT: NCT05436379 · COMPLETED

NCT IDNCT05436379
StatusCOMPLETED
Start Date2022-06-17
Completion2025-11-30
SponsorErika Forbes (OTHER)
First posted
Last updated

Brief Summary

The investigators will administer theta burst stimulation (TBS) in efforts to observe a decrease in severity of reported depression symptoms. A subset of participants will receive positive affect training during this intervention.

Frequently Asked Questions

What is Treatment, Emotion, and Neuromodulation of Depression (TREND) Study?

Treatment, Emotion, and Neuromodulation of Depression (TREND) Study is a clinical trial registered under NCT05436379. Current status: COMPLETED.

What is the status of NCT05436379?

The current status of NCT05436379 (Treatment, Emotion, and Neuromodulation of Depression (TREND) Study) is: COMPLETED.

When did Treatment, Emotion, and Neuromodulation of Depression (TREND) Study start?

Treatment, Emotion, and Neuromodulation of Depression (TREND) Study started on 2022-06-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑